Hirequest Inc

Aktienanalyse zu Hirequest Inc (HQI)

$16.380

+0.357 (+2.18%)Zum Schluss

Loading chart…
High
17.090
Open
16.030
VWAP
16.50
Vol
25.42K
Mkt Cap
172.20M
Low
16.030
Amount
419.50K
EV/EBITDA, TTM
13.40

HireQuest, Inc. is a franchisor of direct dispatch, executive search, and commercial staffing solutions for HireQuest Direct, HireQuest Health, MRINetwork, Snelling, and TradeCorp across the United States and international markets. The Company provides staffing solutions across industries, including construction, light industrial, healthcare, finance, manufacturing, cybersecurity, and engineering. HireQuest Direct focuses on daily work/daily pay jobs primarily for construction and light industrial customers. TradeCorp focuses on short-term skilled construction jobs. HireQuest Health specializes in skilled personnel in the healthcare and dental industries. Snelling and HireQuest focus on longer-term staffing positions in the light industrial and administrative arenas. Northbound, MRI, SearchPath, and Sales Consultants focus on executive, managerial, and professional recruitment services, although they also offer short-term consultant services.

AI analysis of Hirequest Inc (HQI)

buy

HireQuest Inc (HQI) is a good buy right now due to its recent strong financial performance, including a 6% year-over-year revenue growth in Q2 2026, which is the first growth since Q3 2024, and a significant increase in net income to $2.7 million ($0.19 per share). Additionally, the stock has a forward P/E ratio of 21.88, which is reasonable given its growth prospects. The main risk is the recent 4.43% decline over the last five days, indicating potential volatility.

Bewertungskennzahlen

The current forward P/E ratio for Hirequest Inc (HQI) is 21.88, compared to its 5-year average forward P/E of 22.12.

Forward P/E

Fair
5Y Average P/E
22.12
Current P/E
21.88
Überbewertet
32.47
Unterbewertet
11.77

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
12.73
Current EV/EBITDA
13.40
Überbewertet
16.81
Unterbewertet
8.66

Forward P/S

Fair
5Y Average P/S
6.06
Current P/S
6.85
Überbewertet
7.79
Unterbewertet
4.32

Alphio AI Price Scenarios for HQI

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HQI

$8.97

Szenariopreis

B

Base

Base · 50%HQI

$8.11

Szenariopreis

B

Bear

Bear · 25%HQI

$8.02

Szenariopreis

Event-Zeitleiste

2026-08-10 (ET)

17:00:00

HireQuest Reports Q2 Revenue of $8.1M

17:00:00

HireQuest Reports Q2 Revenue of $8.1M

2026-05-27 (ET)

08:10:00

TrueBlue Rejects HireQuest's $105 Million Acquisition Proposal

2026-05-12 (ET)

16:20:00

HireQuest Reports Q1 Revenue of $6.5M, Down Year-over-Year

2026-03-30 (ET)

16:10:00

HireQuest Reports Q4 Revenue of $7M

News

HQI FAQ — answered by Alphio AI

HireQuest, Inc. is a franchisor of direct dispatch, executive search, and commercial staffing solutions for HireQuest Direct, HireQuest Health, MRINetwork, Snelling, and TradeCorp across the United States and international markets. The Company provides staffing solutions across industries, including construction, light industrial, healthcare, finance, manufacturing, cybersecurity, and engineering. HireQuest Direct focuses on daily work/daily pay jobs primarily for construction and light industrial customers. TradeCorp focuses on short-term skilled construction jobs. HireQuest Health specializes in skilled personnel in the healthcare and dental industries. Snelling and HireQuest focus on longer-term staffing positions in the light industrial and administrative arenas. Northbound, MRI, SearchPath, and Sales Consultants focus on executive, managerial, and professional recruitment services, although they also offer short-term consultant services. It operates in the Industrials sector (SERVICES-HELP SUPPLY SERVICES industry).

HireQuest Inc (HQI) is a good buy right now due to its recent strong financial performance, including a 6% year-over-year revenue growth in Q2 2026, which is the first growth since Q3 2024, and a significant increase in net income to $2.7 million ($0.19 per share). Additionally, the stock has a forward P/E ratio of 21.88, which is reasonable given its growth prospects. The main risk is the recent 4.43% decline over the last five days, indicating potential volatility.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten